- Home
- NMRA vs BCAL Comparison
NMRA vs BCAL Comparison
Compare NMRA & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NMRA | BCAL |
|---|---|---|
| Founded | 2019 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.0M | 578.3M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NMRA | BCAL |
|---|---|---|
| Price | $1.72 | $18.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $7.50 | ★ $20.67 |
| AVG Volume (30 Days) | ★ 1.2M | 137.6K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | 5.23 | ★ 777.27 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.67 |
| P/E Ratio | ★ N/A | $44.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $14.07 |
| 52 Week High | $3.65 | $20.47 |
Technical Indicators
Market Signals| Indicator | NMRA | BCAL |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 49.07 |
| Support Level | $1.67 | $18.49 |
| Resistance Level | $1.95 | $19.21 |
| Average True Range (ATR) | 0.13 | 0.43 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 15.38 | 58.70 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.